Mosapride citrate dihydrate is a stable crystalline form of mosapride citrate used as a gastroprokinetic API. Its dihydrate form ensures improved stability, reproducibility, and solubility for pharmaceutical formulations. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mosapride citrate salt dihydrate and 4-Amino-5-chloro-2-ethoxy-N-{[(2RS)-4-(4-fluorobenzyl)morpholin-2-yl]methyl}benzamide monocitrate dihydrate. Its PubChem CID is 6918047.
Mosapride citrate dihydrate
| CAS No | 86030-72-0 |
|---|---|
| Molecular Formula | C27H37ClFN3O12 |
| Molecular Weight | 650.0 g/mol |
| Synonyms | 4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;2-hydroxypropane-1,2,3-tricarboxylic acid;dihydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mosapride citrate dihydrate is a stable crystalline form of mosapride citrate used as a gastroprokinetic API. Its dihydrate form ensures improved stability, reproducibility, and solubility for pharmaceutical formulations.
The listed CAS number is 86030-72-0.
The listed molecular formula is C27H37ClFN3O12.
The listed molecular weight is 650.0 g/mol.
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;2-hydroxypropane-1,2,3-tricarboxylic acid;dihydrate.
The source lists Mosapride citrate salt dihydrate and 4-Amino-5-chloro-2-ethoxy-N-{[(2RS)-4-(4-fluorobenzyl)morpholin-2-yl]methyl}benzamide monocitrate dihydrate.